ADVL1416: A Phase 1 study of Ramucirumab, a Human Monoclonal Antibody Against the Vascular Endothelial Growth Factor-2 (VEGFR-2) Receptor in Children with Refractory Solid Tumors, including CNS Tumors

  • Goldman, Stewart (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/1612/31/19

Funding

  • Children's Hospital of Philadelphia
  • Eli Lilly and Company